Estimate mortality in patients with severe alcoholic hepatitis not responding to corticosteroid therapy
The Lille model was developed to provide early recognition of patients with severe alcoholic hepatitis not responding to corticosteroids. The model was developed by logistic regression and examined baseline data and a change in bilirubin at day 7. The final model included age, renal function, albumin, prothrombin time, bilirubin at baseline, and bilirubin at day 7.
The Lille model was able to predict mortality at 6 months, with an AUROC curve of 0.85 in the validation cohort.
Lower scores indicated more improvement (in response to corticosteroids).
Lille formula:
Where R = 3.19 - (0.101 X age) + (0.147 X baseline albumin) + (0.0165 X change in bilirubin level) - (0.206 X creatinine) - (0.0065 X baseline bilirubin) - (0.0096 X prothrombin time)
Louvet A, Naveau S, Abdelnour M et al.
The Lille model was developed to provide early recognition of patients with severe alcoholic hepatitis not responding to corticosteroids. The model was developed by logistic regression and examined baseline data and a change in bilirubin at day 7. The final model included age, renal function, albumin, prothrombin time, bilirubin at baseline, and bilirubin at day 7.
The Lille model was able to predict mortality at 6 months, with an AUROC curve of 0.85 in the validation cohort.
Lower scores indicated more improvement (in response to corticosteroids).
Lille formula:
Where R = 3.19 - (0.101 X age) + (0.147 X baseline albumin) + (0.0165 X change in bilirubin level) - (0.206 X creatinine) - (0.0065 X baseline bilirubin) - (0.0096 X prothrombin time)
Louvet A, Naveau S, Abdelnour M et al.
© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.
